These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2786690)

  • 1. Effect of heparin on the inhibition of the contact system enzymes.
    Colman RW; Scott CF; Pixley RA; de la Cadena RA
    Ann N Y Acad Sci; 1989; 556():95-103. PubMed ID: 2786690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant activities of heparin and fragments.
    Barrowcliffe TW; Thomas DP
    Ann N Y Acad Sci; 1989; 556():132-45. PubMed ID: 2660683
    [No Abstract]   [Full Text] [Related]  

  • 3. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.
    Scott CF; Colman RW
    Blood; 1989 May; 73(7):1873-9. PubMed ID: 2785417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
    Soons H; Tans G; Hemker HC
    Biochem J; 1988 Dec; 256(3):815-20. PubMed ID: 3265623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of factor XIa by antithrombin III.
    Soons H; Janssen-Claessen T; Tans G; Hemker HC
    Biochemistry; 1987 Jul; 26(15):4624-9. PubMed ID: 3499176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a heparin binding site on the heavy chain of factor XI.
    Zhao M; Abdel-Razek T; Sun MF; Gailani D
    J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
    Carlson TH; Kolman MR; Frees A; Babcock T
    Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of heparin action.
    Shore JD; Olson ST; Craig PA; Choay J; Björk I
    Ann N Y Acad Sci; 1989; 556():75-80. PubMed ID: 2786689
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
    Scott CF; Wenzel HR; Tschesche HR; Colman RW
    Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA; Olson ST; Shore JD
    J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow and the inhibition of prothrombinase by antithrombin III and heparin.
    Schoen P; Lindhout T
    Blood; 1991 Jul; 78(1):118-24. PubMed ID: 2070046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Lewis JH; Colman RW
    Trans Assoc Am Physicians; 1985; 98():344-51. PubMed ID: 3879844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.